BG
IRWD icon

BlackRock Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

BlackRock Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.94M Buy
151,771
+23,553
+18% +$297K ﹤0.01% 1786
2016
Q3 		$1.71M Sell
128,218
-763
-0.6% -$8.92K ﹤0.01% 1729
2016
Q2 		$1.41M Sell
128,981
-20,987
-14% -$205K ﹤0.01% 1764
2016
Q1 		$1.37M Buy
149,968
+38,679
+35% +$319K ﹤0.01% 1754
2015
Q4 		$1.08M Sell
111,289
-25,252
-18% -$244K ﹤0.01% 1855
2015
Q3 		$1.19M Buy
136,541
+30,283
+28% +$283K ﹤0.01% 1780
2015
Q2 		$1.07M Buy
106,258
+8,061
+8% +$93.7K ﹤0.01% 1925
2015
Q1 		$1.32M Buy
98,197
+14,610
+17% +$192K ﹤0.01% 1713
2014
Q4 		$1.07M Buy
83,587
+2,260
+3% +$25.9K ﹤0.01% 1840
2014
Q3 		$882K Buy
81,327
+22,447
+38% +$257K ﹤0.01% 1865
2014
Q2 		$756K Sell
58,880
-34,584
-37% -$376K ﹤0.01% 2005
2014
Q1 		$965K Buy
93,464
+7,547
+9% +$84.9K ﹤0.01% 2000
2013
Q4 		$835K Buy
85,917
+5,734
+7% +$51.5K ﹤0.01% 2049
2013
Q3 		$795K Sell
80,183
-48,302
-38% -$474K ﹤0.01% 2035
2013
Q2 		$1.07M Buy
+128,485
New +$1.56M ﹤0.01% 1704

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's IRWD Position: Q4 2016 in Review

BlackRock Group increased its Ironwood Pharmaceuticals (IRWD) stake by 18% in Q4 2016, buying an estimated $297K and bringing the position to 151,771 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1786.

BlackRock Group first reported a position in IRWD in Q2 2013 and has held it in 15 quarters since. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • BlackRock Group held 151,771 shares of Ironwood Pharmaceuticals worth $1.94M as of Q4 2016.
  • BlackRock Group bought 23,553 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $297K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1786 holding.
  • BlackRock Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.